End-to-end R&D software platform for biopharma, chemistry, and materials science
Dotmatics operates a portfolio of specialized research tools (GraphPad Prism, Geneious, SnapGene, Protein Metrics, LabArchives) serving 2+ million researchers across biopharma, chemicals, and materials enterprises. The tech stack reveals a hybrid Windows-desktop + cloud-native strategy: legacy .NET/WPF (GraphPad Prism, SnapGene) paired with modern Node.js/React/TypeScript services on AWS. Active projects signal aggressive modernization—serverless pipelines, GPU-native solvers, and AI-powered R&D platform development—while security and data reliability remain top friction points. Hiring is accelerating with heavy engineering focus (19 roles), suggesting capacity constraints in platform consolidation and new feature velocity.
Dotmatics builds end-to-end software for R&D teams across biopharma, chemical, and materials science sectors. The platform integrates workflows, data management, and domain-specific applications spanning biology, chemistry, formulations, flow cytometry, and bioinformatics. Core products include GraphPad Prism (statistical analysis), Geneious and SnapGene (sequence design and analysis), and LabArchives (electronic lab notebooks). The company operates across 501–1,000 employees from Boston with active hiring in the US, Canada, and Ireland. Revenue concentration likely sits in subscription renewals and enterprise licensing of mature tools, with emerging opportunities in AI-augmented R&D workflows and digital transformation across materials science.
Legacy: .NET Core, WPF, C# for desktop applications (GraphPad Prism, SnapGene). Modern: Node.js, React, TypeScript for web services; Java and Python for backend logic. Infrastructure: AWS (RDS, ECR, CloudFront, WAF, CloudTrail). Testing: MSTest, NUnit, xUnit; Docker containerization. Third-party: Mendix (low-code), Teamcenter (PLM integration).
Active projects include: serverless data pipelines, GPU-native multiphysics solvers, AI-powered R&D platform development, Node.js/TypeScript service architecture, electronic lab notebook (ELN), and scalable enterprise desktop solutions for biopharma. Top-of-funnel growth and high-volume hiring support are parallel initiatives.
Other companies in the same industry, closest in size